Introduction 12
DOC-001000 Ver 6 Clearway 2 User Manual .
Contraindications to IPPB Mode
Careful evaluation of the patient will need to be carried out prior to
commencement of IPPB treatment. Contraindications to using IPPB mode
include contraindications in page 11, and the following, but are not limited to:
• Tension pneumothorax
• Uncontrolled asthma
• Surgical emphysema
• Vomiting
• Cardiovascular instability
• Flail chest
Considerations before Use
Do not use the Clearway 2 with patients with the below
conditions without specific instructions from your referring
clinician.
A risk assessment and guidance should be provided. If the patient develops
any of the below symptoms/conditions, you must consult the referring
clinician before continuing use of Clearway 2.
• Bulbar insufficiency
• Nausea or risk of vomiting
• Gastrointestinal feed
• Changes in symptoms or effectiveness of the treatment
Undesirable Side Effects
If undesirable side effects are witnessed or reported, treatment should stop
immediately, and the referring or responsible physician must be notified. If
treatment becomes ineffective at clearing secretions and augmenting a cough,
please contact your referring physician/clinician or home care provider.